CLINICAL_TRIALS
trial_result
· 2019-09-04
Clinical Trial Update: Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI) [Phase 3]
Summary
Phase 3 trial update on intravenous methylnaltrexone bromide for postoperative ileus has completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch Health Americas, Inc. | Conditions: Post-Operative Ileus (POI) | Phase 3 | Status: COMPLETED | Results posted: 2019-09-04